756 Federal Register / Vol. 84, No. 21 / Thursday, January 31, 2019 / Notices 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Total .............................................................................. 300 ........................ 600 ........................ 40.02 

Amy P. McNulty, 

Acting Director, Division of the Executive 

Secretariat. 

[FR Doc. 2019–00394 Filed 1–30–19; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Meeting of the Advisory Commission 

on Childhood Vaccines 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Advisory Commission on 

Childhood Vaccines (ACCV) has 

scheduled public meetings for the 2019 

calendar year (CY). Information about 

ACCV, agendas, and materials for these 

meetings can be found on the ACCV 

website at: http://www.hrsa.gov/ 

advisorycommittees/childhoodvaccines/ 

index.html. 

DATES: ACCV meetings will begin at 

10:00 a.m. ET on March 7–8, 2019; June 

6–7, 2019; September 5–6, 2019; and 

December 5–6, 2019. 

ADDRESSES: Meetings may be held inperson, by teleconference, and/or Adobe 

Connect webinar. In-person ACCV 

meetings will be held at 5600 Fishers 

Lane, Rockville, Maryland 20857. 

Instructions for joining the meetings 

either in person or remotely will be 

posted on the ACCV website 30 

business days before the date of the 

meeting. For meeting information 

updates, go to the ACCV website 

meeting page: https://www.hrsa.gov/ 

advisory-committees/vaccines/ 

meetings.html. 

FOR FURTHER INFORMATION CONTACT: 

Annie Herzog, Program Analyst, 

Division of Injury Compensation 

Programs (DICP), HRSA, 5600 Fishers 

Lane, 08N146B, Rockville, Maryland 

20857; 301–443–6593; or aherzog@

hrsa.gov. 

SUPPLEMENTARY INFORMATION: The ACCV 

was established by section 2119 of the 

Public Health Service Act (42 U.S.C. 

300aa–19), as enacted by Public Law 

(Pub. L.) 99–660, and as subsequently 

amended, and advises the Secretary of 

HHS (Secretary) on issues related to 

implementation of the National Vaccine 

Injury Compensation Program (VICP). 

For CY 2019 meetings, agenda items 

may include, but are not limited to, 

updates from DICP, the Department of 

Justice, the National Vaccine Program 

Office, the Immunization Safety Office, 

National Institute of Allergy and 

Infectious Diseases, and the Center for 

Biologics Evaluation and Research. 

Since priorities dictate meeting times, 

be advised that locations and agenda 

items are subject to change. Refer to the 

ACCV website listed above for all 

current and updated information 

concerning the CY 2019 ACCV 

meetings, including draft agendas and 

meeting materials that will be posted 

before the meeting. 

Members of the public will have the 

opportunity to provide comments. 

Public participants may submit written 

statements in advance of the scheduled 

meeting(s). Oral comments will be 

honored in the order they are requested 

and may be limited as time allows. 

Requests to submit a written statement 

or make oral comments to the ACCV 

should be sent to Annie Herzog using 

the contact information above at least 

five business days before the meeting 

date(s). 

Individuals who need special 

assistance or another reasonable 

accommodation should notify Annie 

Herzog at the address and phone 

number listed above at least 10 business 

days before the meeting(s) they wish to 

attend. Since all in person meetings will 

occur in a federal government building, 

attendees must go through a security 

check to enter the building. Non-U.S. 

Citizen attendees must notify HRSA of 

their planned attendance at least 10 

business days prior to the meeting in 

order to facilitate their entry into the 

building. All attendees are required to 

present government-issued 

identification prior to entry. 

Amy P. McNulty, 

Acting Director, Division of the Executive 

Secretariat. 

[FR Doc. 2019–00439 Filed 1–30–19; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Agency Information Collection 

Activities: Submission to OMB for 

Review and Approval; Public Comment 

Request; Bureau of Health Workforce 

Performance Data Collection, OMB No. 

0915–0061—Revision 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: In compliance with of the 

Paperwork Reduction Act of 1995, 

HRSA has submitted an Information 

Collection Request (ICR) to the Office of 

Management and Budget (OMB) for 

review and approval. Comments 

submitted during the first public review 

of this ICR will be provided to OMB. 

OMB will accept further comments from 

the public during the review and 

approval period. 

DATES: Comments on this ICR should be 

received no later than March 4, 2019. 

ADDRESSES: Submit your comments, 

including the ICR Title, to the desk 

officer for HRSA, either by email to 

OIRA_submission@omb.eop.gov or by 

fax to 202–395–5806. 

FOR FURTHER INFORMATION CONTACT: To 

request a copy of the clearance requests 

submitted to OMB for review, email Lisa 

Wright-Solomon, the HRSA Information 

Collection Clearance Officer at 

paperwork@hrsa.gov or call (301) 443– 

1984. 

SUPPLEMENTARY INFORMATION: 

Information Collection Request Title: 

Bureau of Health Workforce 

Performance Data Collection, OMB No. 

0915–0061—Revision. 

Abstract: Over 40 Bureau of Health 

Workforce (BHW) programs award 

grants to health professions schools and 

training programs across the United 

States to develop, expand, and enhance 

training, and to strengthen the 

distribution of the health workforce. 

These programs are governed by the 

Public Health Service Act (42 U.S.C. 201 

et seq.), specifically Titles III, VII, and 

VIII. Performance information about 


amozie on DSK3GDR082PROD with NOTICES1